基本信息
浏览量:214
职业迁徙
个人简介
Research Focus:
Dr. Ressler’s Neurobiology of Fear Laboratory, founded in 2001 at Emory University and relocated to McLean Hospital in 2015, investigates the molecular, genetic, epigenetic, and neural circuit mechanisms underlying fear processes through an integration of animal models and human genetic research. The hope is that gaining a better understanding of how fear works in the brain will contribute to the development of new treatments, and possibly even prevention, of fear-based psychiatric illnesses.
To truly understand and treat complex neuropsychiatric disorders, we need to know what behaviors are affected, which brain regions are involved, which genes, molecules, and cell types in these regions might be involved, and how the environment affects the propensity to develop these disorders. Dr. Ressler’s research encompasses these questions, with focus on fear and post-traumatic stress disorder (PTSD).
Dr. Ressler’s group uses well-established mouse models to examine different aspects of fear learning and investigate the role of different brain regions, in particular the amygdala, in fear processing. Furthermore, the lab examines how these mechanisms may be involved in the development of fear-based disorders, such as PTSD, phobic disorders, and panic disorder. Utilizing data collected from human clinical populations, Dr. Ressler and his team identify genetic traits and neural processes that may contribute to the underlying causes of these illnesses and provide novel targets for animal models research.
An important observation in recent years is that there are a number of different learning components involved in the fear response following trauma exposure and recovery. Evidence suggests that trauma exposure in the past (in particular, child abuse), prior to the current ‘index trauma’ is associated with increased risk for PTSD onset. Furthermore, twin studies suggest approximately 30-40% genetic heritability. Together these components constitute differential pre-existing sensitivity.
During the minutes to hours to days following trauma exposure, trauma memory remains in a labile state, called the consolidation period. There are many exciting areas of inquiry suggesting that new pharmacotherapeutic and psychotherapeutic approaches can be initiated that may inhibit the emotional component of fear memory consolidation, without affecting the explicit memory formation. Such an approach could prevent the severe emotional reactions that underlie later development of PTSD. There are several additional cognitive mechanisms that are associated with pathological reactions such as generalization and sensitization of trauma memory reminders. In contrast, the mechanisms of discrimination and extinction of memory serve to counter these processes. By understanding multiple different components of fear memory formation and modulation in humans and mice, a number of novel, powerful, and targeted treatment and intervention approaches may become possible.
Dr. Ressler’s Neurobiology of Fear Laboratory, founded in 2001 at Emory University and relocated to McLean Hospital in 2015, investigates the molecular, genetic, epigenetic, and neural circuit mechanisms underlying fear processes through an integration of animal models and human genetic research. The hope is that gaining a better understanding of how fear works in the brain will contribute to the development of new treatments, and possibly even prevention, of fear-based psychiatric illnesses.
To truly understand and treat complex neuropsychiatric disorders, we need to know what behaviors are affected, which brain regions are involved, which genes, molecules, and cell types in these regions might be involved, and how the environment affects the propensity to develop these disorders. Dr. Ressler’s research encompasses these questions, with focus on fear and post-traumatic stress disorder (PTSD).
Dr. Ressler’s group uses well-established mouse models to examine different aspects of fear learning and investigate the role of different brain regions, in particular the amygdala, in fear processing. Furthermore, the lab examines how these mechanisms may be involved in the development of fear-based disorders, such as PTSD, phobic disorders, and panic disorder. Utilizing data collected from human clinical populations, Dr. Ressler and his team identify genetic traits and neural processes that may contribute to the underlying causes of these illnesses and provide novel targets for animal models research.
An important observation in recent years is that there are a number of different learning components involved in the fear response following trauma exposure and recovery. Evidence suggests that trauma exposure in the past (in particular, child abuse), prior to the current ‘index trauma’ is associated with increased risk for PTSD onset. Furthermore, twin studies suggest approximately 30-40% genetic heritability. Together these components constitute differential pre-existing sensitivity.
During the minutes to hours to days following trauma exposure, trauma memory remains in a labile state, called the consolidation period. There are many exciting areas of inquiry suggesting that new pharmacotherapeutic and psychotherapeutic approaches can be initiated that may inhibit the emotional component of fear memory consolidation, without affecting the explicit memory formation. Such an approach could prevent the severe emotional reactions that underlie later development of PTSD. There are several additional cognitive mechanisms that are associated with pathological reactions such as generalization and sensitization of trauma memory reminders. In contrast, the mechanisms of discrimination and extinction of memory serve to counter these processes. By understanding multiple different components of fear memory formation and modulation in humans and mice, a number of novel, powerful, and targeted treatment and intervention approaches may become possible.
研究兴趣
论文共 1008 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Adam X Maihofer,Andrew Ratanatharathorn,Sian M J Hemmings,Karen H Costenbader,Vasiliki Michopoulos,Renato Polimanti,Alex O Rothbaum,Soraya Seedat, Elizabeth A Mikita, CHARGE Inflammation Working Group, Psychiatric Genomics Consortium PTSD Working Group,Alicia K Smith,
Translational psychiatryno. 1 (2024): 172-172
biorxiv(2024)
Lucy J. Allbaugh,Grace George,Torsten Klengel, Alex Profetto, Lucas Marinack, Fiona O'Malley,Kerry Ressler
Journal of Affective Disorders (2024): 224-231
BaDoi N. Phan,Madelyn H. Ray,Xiangning Xue, Chen Fu,Robert J. Fenster,Stephen J. Kohut,Jack Bergman,Suzanne N. Haber,Kenneth M. McCullough, Madeline K. Fish,Jill R. Glausier,Qiao Su,
Brien Culhane,Habiballah Rahimi Eichi, Robert Patterson,Agustin Yip, Alexander Pandina,Einat Liebenthal,Kerry Ressler,Justin Baker
Biological Psychiatryno. 10 (2024): S182
Jonathan Vogelgsang,Vincent Holstein,Shu Dan, Joshua Abston, Tom McCoy,Torsten Klengel,Kerry Ressler,Sabina Berretta
Biological Psychiatryno. 10 (2024): S168
Biological Psychiatryno. 10 (2024): S34-S35
Leland Fleming,Kyoko Ohashi,Seyma Katrinli,Alicia Smith,Michelle Bosquet Enlow, Karlen Lyons-Ruth,Martin Teicher,Torsten Klengel,Kerry Ressler
Biological Psychiatryno. 10 (2024): S248
Gabriele Chelini,Hadi Mirzapourdelavar,Peter Durning,David Baidoe-Ansah,Manveen K. Sethi, Sinead M. O’Donovan,Torsten Klengel,Luigi Balasco,Cristina Berciu, Anne Boyer-Boiteau,Robert McCullumsmith,Kerry J. Ressler,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn